癌变·畸变·突变 ›› 2008, Vol. 20 ›› Issue (4): 303-307.doi: 10.3969/j.issn.1004-616x.2008.04.014

• 论著 • 上一篇    下一篇

CXCR4表达上调与HER2介导乳腺癌转移的相关性研究

杨清玲1/ 丁勇兴2/ 李成华2/ 陈昌杰1/ 章　菊1/ 王　惠1   

  1. 1.蚌埠医学院生化与分子生物学教研室，安徽 蚌埠　233000；2.蚌埠市中心医院肿瘤科，安徽蚌埠　233000
  • 收稿日期:2007-09-11 修回日期:2007-10-30 出版日期:2008-07-30 发布日期:2008-07-30

Upregulation of CXCR4 and HER2_mediated Breast Cancer Metastasis

YANG Qing_ling1, DING Yong_xing2, LI Cheng_hua2,CHEN Chang_jie1, ZHANG Ju1, WANG Hui1   

  1. 1.Department of Biochemistry ＆ Molecular Biology,Bengbu Medical College, Bengbu 233000,Anhui; 2. Branch of Tumor, The Central Hospital of Bengbu, Bengbu 233000, Anhui,China
  • Received:2007-09-11 Revised:2007-10-30 Online:2008-07-30 Published:2008-07-30

PDF

2599

摘要： 背景与目的： 检测CXCR4和HER2在乳腺患者的表达水平，观察HER2特异性抗体Herceptin对CXCR4表达和乳腺癌细胞体外转移活性的抑制作用。 材料与方法： 采用免疫组化法，检测临床不同时期乳腺癌组织CXCR4和HER2的表达水平；采用Western blot检测Herceptin作用后CXCR4蛋白表达，RT_PCR技术检测CXCR4 mRNA的表达；采用趋化实验和粘附实验检测Herceptin对HER2不同表达水平的乳腺癌细胞趋化和粘附活性的影响。 结果： CXCR4表达与乳腺癌细胞淋巴结转移状况、乳腺癌组织学分期及HER2的表达呈正相关(P值分别为0.032、0.000和0.015)；在高表达HER2的乳腺癌细胞株SKBR3中，Herceptin可下调CXCR4的蛋白及mRNA的表达(P<0.05)，并抑制其趋化和粘附活性(P<0.05)。 结论： 在HER2介导的肿瘤转移中，CXCR4表达上调可能是关键因素。

关键词: CXCR4, HRE2, 乳腺肿瘤, 转移

Abstract: BACKGROUND AND AIM: We evaluated the expression of CXCR4 and HER2, the inhibition of Herceptin on CXCR4 expression and the in vitro metastatic action in breast cancer cells. MATERIALS AND METHODS: Biomarker expression levels in paraffin_embedded tissue sections of breast cancer were evaluated using immunohistochemical staining. The protein expression of CXCR4 was studied by Western blot and the mRNA expression was by RT_PCR after treatment with Herceptin . Adhesion and chemotaxis assays were used to evalvate the effect of Herceptin on breast cancer cells with different HER2 expressions. RESULTS: Cytoplasmic CXCR4 was positively correlated with lymph node－positive tumors(P=0.032)and different stage of breast cancer(P=0.000)and the expression of HER2(P=0.015). The protein and mRNA expressions of CXCR4 were decreased after treatment with Herceptin in breast cancer cells with HER2 overexpression(P<0.05)and activity of cell adherence to fibronectin(FN) and migration to SDF_1α were inhibited. CONCLUSION: HER2_mediated homing to metastatic organs and upregulation of CXCR4 may be key factors for HER2_mediated breast cancer metastasis.

Key words: CXCR4, HER2, breast cancer, metastasis

版权所有 ©2019 《癌变·畸变·突变》编辑部 E-mail： office@egh.net.cn
本系统由北京玛格泰克科技发展有限公司设计开发 技术支持：support@magtech.com.cn
粤ICP备 10216025号